Home » Headlines » Currently Reading:

Morning Headlines 12/19/17

December 18, 2017 Headlines No Comments

CDC director tells staff ‘there are no banned words,’ while not refuting report

CDC Director Brenda Fitzgerald sent an internal email this week assuring staff that the agency would always be a science-based institution and noting that reports that the Trump administration released a list of banned phrases for the CDC, including “evidence-based” and “science-based” were not entirely accurate and would not impact the agency’s work. In a Sunday morning tweet she reiterated that “there are no banned words at CDC.”

Highmark, Penn State Health officially sign off on partnership deal

Highmark finalizes a $1 billion partnership with Penn State Health that will establish a Central Pennsylvania health network that will use Highmark’s insurance data and Penn State’s delivery network to build a cost effective care delivery model.

ONC launches tool to collect patient demographic data

Responding to reports that a vast majority of medical errors occur because of erroneous patient data, ONC and the CMMI Institute release the Patient Demographic Data Quality framework, a collection of best practice recommendations on collecting and improving patient data.

FDA takes more aggressive stance toward homeopathic drugs

The FDA is taking a tougher stance on homeopathic drugs, specifically those containing potentially harmful ingredients or being marketed for cancer, heart disease, or opioid and alcohol addictions.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Vaporware?: JTR, Cerner is re-tooling itself from a software company (sic) into a service company. The company needs a place to put ...
  • Dave Butler: Many similar issues that I've found as well during my time with provider groups. The EHRs screen can be really busy and ...
  • Justa Trench Rat: Nice to see Cerner continuing with their new campus. I am sure our implementation of their highly questionable revenue ...
  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links